Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2008

01.06.2008

Cancer survivors with unmet needs were more likely to use complementary and alternative medicine

verfasst von: Jun J. Mao, Steve C. Palmer, Joseph B. Straton, Peter F. Cronholm, Shimrit Keddem, Kathryn Knott, Marjorie A. Bowman, Frances K. Barg

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite advancements in cancer care, cancer survivors continue to experience a substantial level of physical and emotional unmet needs (UMN). This study aims to determine the relationship between patients’ perceived UMN and their use of complementary and alternative medicine (CAM) to help with cancer problems during and after treatment.

Methods

A mailed, cross-sectional survey was completed by 614 cancer survivors identified through the Pennsylvania Cancer Registry 3.5 to 4 years from initial diagnosis. Relationships among UMN and CAM use along with clinical and socio-demographic factors were examined.

Results

Respondents who identified any UMN were 63% more likely to report CAM use than those without UMN (58% vs. 36%), p < 0.001. UMN remained the only independent predictor (adjusted odds ratio = 2.30, 95% confidence interval = 1.57–3.36, p < 0.001) of CAM use in a multivariate logistic regression model that included age, sex, marital status, education, previous chemotherapy and radiotherapy. Adjusted for covariates, UMN in domains of emotional, physical, nutritional, financial, informational, treatment-related, employment-related, and daily living activities were all related to CAM use, whereas UMN in transportation, home care, medical staff, family and spirituality were not related to CAM use. Patients who experienced multiple types of unmet needs were also more likely to use multiple types of CAM (p < 0.001 for model).

Conclusions

Cancer survivors who experienced unmet needs within the existing cancer treatment and support system were more likely to use CAM to help with cancer problems. Research is needed to determine if appropriate CAM use decreases unmet needs among cancer survivors.
Literatur
1.
Zurück zum Zitat Barg FK, Cronholm PF, Straton JB, Keddem S, Knott K, Grater J, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986–2005. Cancer 2007;110(3):631–9.PubMedCrossRef Barg FK, Cronholm PF, Straton JB, Keddem S, Knott K, Grater J, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986–2005. Cancer 2007;110(3):631–9.PubMedCrossRef
2.
Zurück zum Zitat Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer 2005;104(11 Suppl):2543–8.PubMedCrossRef Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer 2005;104(11 Suppl):2543–8.PubMedCrossRef
3.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006.
5.
Zurück zum Zitat National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15–17 2002. J Natl Cancer Inst 2003;95(15):1110–7.CrossRef National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15–17 2002. J Natl Cancer Inst 2003;95(15):1110–7.CrossRef
6.
Zurück zum Zitat Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330(9):592–6.PubMedCrossRef Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330(9):592–6.PubMedCrossRef
7.
Zurück zum Zitat Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19(3):895–908.PubMed Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19(3):895–908.PubMed
8.
Zurück zum Zitat Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 2007;20(5):434–43.PubMedCrossRef Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med 2007;20(5):434–43.PubMedCrossRef
9.
Zurück zum Zitat Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring. Cancer 2005;104(11 Supplement):2565–76.PubMedCrossRef Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring. Cancer 2005;104(11 Supplement):2565–76.PubMedCrossRef
10.
Zurück zum Zitat Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, et al. Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 2005;23(4):35–60.PubMedCrossRef Roberts CS, Baker F, Hann D, Runfola J, Witt C, McDonald J, et al. Patient–physician communication regarding use of complementary therapies during cancer treatment. J Psychosoc Oncol 2005;23(4):35–60.PubMedCrossRef
11.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94(1):39–49.PubMed Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94(1):39–49.PubMed
12.
Zurück zum Zitat Holland JC, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer 2005;104(11 supplement):2624–37.PubMedCrossRef Holland JC, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer 2005;104(11 supplement):2624–37.PubMedCrossRef
13.
Zurück zum Zitat Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328(4):246–52.PubMedCrossRef Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328(4):246–52.PubMedCrossRef
14.
Zurück zum Zitat Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998;83(4):777–82.PubMedCrossRef Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998;83(4):777–82.PubMedCrossRef
15.
Zurück zum Zitat Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005;13(10):806–11.PubMedCrossRef Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005;13(10):806–11.PubMedCrossRef
16.
Zurück zum Zitat Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4.PubMedCrossRef Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4.PubMedCrossRef
17.
Zurück zum Zitat Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340(22):1733–9.PubMedCrossRef Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340(22):1733–9.PubMedCrossRef
18.
Zurück zum Zitat Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med 2007;15(1):21–9.PubMedCrossRef Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med 2007;15(1):21–9.PubMedCrossRef
19.
Zurück zum Zitat Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-oncology 2003;12(1):59–67.PubMedCrossRef Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-oncology 2003;12(1):59–67.PubMedCrossRef
20.
Zurück zum Zitat Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90(2):139–48.PubMedCrossRef Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90(2):139–48.PubMedCrossRef
21.
Zurück zum Zitat Davidson R, Geoghegan L, McLaughlin L, Woodward R. Psychological characteristics of cancer patients who use complementary therapies. Psycho-oncology 2005;14(3):187–95.PubMedCrossRef Davidson R, Geoghegan L, McLaughlin L, Woodward R. Psychological characteristics of cancer patients who use complementary therapies. Psycho-oncology 2005;14(3):187–95.PubMedCrossRef
22.
Zurück zum Zitat Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19(9):2439–48.PubMed Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19(9):2439–48.PubMed
23.
Zurück zum Zitat Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 2007;7:25.PubMedCrossRef Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 2007;7:25.PubMedCrossRef
24.
Zurück zum Zitat Mertens AC, Sencer S, Myers CD, Recklitis C, Kadan-Lottick N, Whitton J, et al. Complementary and alternative therapy use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008;50(1):90–7.PubMedCrossRef Mertens AC, Sencer S, Myers CD, Recklitis C, Kadan-Lottick N, Whitton J, et al. Complementary and alternative therapy use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008;50(1):90–7.PubMedCrossRef
25.
Zurück zum Zitat Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psycho-oncology 2008;17(1):19–25.PubMedCrossRef Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psycho-oncology 2008;17(1):19–25.PubMedCrossRef
26.
Zurück zum Zitat Barnes PM, Power-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Advanced data from vital and health statistics; no. 343. Hyattsville, Maryland: National Center for Health Statistics. 2004. Barnes PM, Power-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Advanced data from vital and health statistics; no. 343. Hyattsville, Maryland: National Center for Health Statistics. 2004.
27.
Zurück zum Zitat National Center for Health Statistics. National Health Interview Survey 2002: National Center for Health Statistics. Hyattsville, Md. Machine Readable Data File and Documentation, 2002: Machine Readable Data File and Documentation. National Center for Health Statistics. National Health Interview Survey 2002: National Center for Health Statistics. Hyattsville, Md. Machine Readable Data File and Documentation, 2002: Machine Readable Data File and Documentation.
28.
Zurück zum Zitat Houts P, Yasko JM, Kahn SB, Schelzel GW, Marconi K. Unmet psychological, social and economic needs of persons with cancer in Pennsylvania. Cancer 1986;58(10):2355–61.PubMedCrossRef Houts P, Yasko JM, Kahn SB, Schelzel GW, Marconi K. Unmet psychological, social and economic needs of persons with cancer in Pennsylvania. Cancer 1986;58(10):2355–61.PubMedCrossRef
29.
Zurück zum Zitat Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18(13):2515–21.PubMed Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18(13):2515–21.PubMed
30.
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18(13):2505–14.PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18(13):2505–14.PubMed
31.
Zurück zum Zitat Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova M, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 1998;51(12):1285–92.PubMedCrossRef Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova M, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 1998;51(12):1285–92.PubMedCrossRef
32.
Zurück zum Zitat Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001;135(5):344–51.PubMed Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001;135(5):344–51.PubMed
33.
Zurück zum Zitat Shumay DM, Maskarinec G, Kakai H, Gotay CC. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 2001;50(12):1067.PubMed Shumay DM, Maskarinec G, Kakai H, Gotay CC. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 2001;50(12):1067.PubMed
34.
Zurück zum Zitat Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 2006;24(32):5112–6.PubMedCrossRef Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol 2006;24(32):5112–6.PubMedCrossRef
35.
Zurück zum Zitat Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin 2005;55(2):109–16.PubMedCrossRef Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin 2005;55(2):109–16.PubMedCrossRef
36.
Zurück zum Zitat Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol 2005;32(2):225–31.PubMedCrossRef Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol 2005;32(2):225–31.PubMedCrossRef
37.
Zurück zum Zitat Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 2006;24(34):5457–64.PubMedCrossRef Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol 2006;24(34):5457–64.PubMedCrossRef
38.
Zurück zum Zitat Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003;21(22):4120–6.PubMedCrossRef Alimi D, Rubino C, Pichard-Leandri E, Fermand-Brule S, Dubreuil-Lemaire ML, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003;21(22):4120–6.PubMedCrossRef
39.
Zurück zum Zitat Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, et al. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage 2007;33(3):258–66.PubMedCrossRef Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, et al. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage 2007;33(3):258–66.PubMedCrossRef
40.
Zurück zum Zitat Vickers AJ, Straus DJ, Fearon B, Cassileth BR. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004;22(9):1731–5.PubMedCrossRef Vickers AJ, Straus DJ, Fearon B, Cassileth BR. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004;22(9):1731–5.PubMedCrossRef
41.
Zurück zum Zitat Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007;15(4):228–37.PubMedCrossRef Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007;15(4):228–37.PubMedCrossRef
42.
Zurück zum Zitat Filshie J, Bolton T, Browne D, Ashley S. Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients—audit and treatment algorithm. Acupunct Med 2005;23(4):171–80.PubMed Filshie J, Bolton T, Browne D, Ashley S. Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients—audit and treatment algorithm. Acupunct Med 2005;23(4):171–80.PubMed
43.
Zurück zum Zitat Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004;28(3):244–9.PubMedCrossRef Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004;28(3):244–9.PubMedCrossRef
44.
Zurück zum Zitat Wilkinson SM, Love SB, Westcombe AM, Gambles MA, Burgess CC, Cargill A, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 2007;25(5):532–9.PubMedCrossRef Wilkinson SM, Love SB, Westcombe AM, Gambles MA, Burgess CC, Cargill A, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 2007;25(5):532–9.PubMedCrossRef
45.
Zurück zum Zitat Ernst E, Pittler MH, Wider B, Boddy K. Complementary/alternative medicine for supportive cancer care: development of the evidence-base. Support Care Cancer 2007;15(5):565–8.PubMedCrossRef Ernst E, Pittler MH, Wider B, Boddy K. Complementary/alternative medicine for supportive cancer care: development of the evidence-base. Support Care Cancer 2007;15(5):565–8.PubMedCrossRef
46.
Zurück zum Zitat IOM (Institute of Medicine). Complementary and alternative medicine in the United States. Washington, DC: The National Academies Press; 2005. IOM (Institute of Medicine). Complementary and alternative medicine in the United States. Washington, DC: The National Academies Press; 2005.
47.
Zurück zum Zitat Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol 2005;23(12):2590–2.PubMedCrossRef Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol 2005;23(12):2590–2.PubMedCrossRef
48.
Zurück zum Zitat Hui KK, Hui EK, Johnston MF. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East–West medicine. Integr Cancer Ther 2006;5(1):56–62.PubMedCrossRef Hui KK, Hui EK, Johnston MF. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East–West medicine. Integr Cancer Ther 2006;5(1):56–62.PubMedCrossRef
49.
Zurück zum Zitat Buchanan DR, White JD, O’Mara AM, Kelaghan JW, Smith WB, Minasian LM. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 2005;23(27):6682–9.PubMedCrossRef Buchanan DR, White JD, O’Mara AM, Kelaghan JW, Smith WB, Minasian LM. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol 2005;23(27):6682–9.PubMedCrossRef
Metadaten
Titel
Cancer survivors with unmet needs were more likely to use complementary and alternative medicine
verfasst von
Jun J. Mao
Steve C. Palmer
Joseph B. Straton
Peter F. Cronholm
Shimrit Keddem
Kathryn Knott
Marjorie A. Bowman
Frances K. Barg
Publikationsdatum
01.06.2008
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2008
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-008-0052-3

Weitere Artikel der Ausgabe 2/2008

Journal of Cancer Survivorship 2/2008 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.